Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Capital Reinvestment Ratio
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Capital Reinvestment Ratio of 7.78x as of December 2024, meaning it reinvests 8% of its operating cash flow (CN¥24.04 Million) in capital expenditures (CN¥187.14 Million). Check how tangible is Hunan Dajiaweikang Pharmaceutical Indust's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Capital Reinvestment Ratio (2019–2024)
This chart tracks Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see 301126 cash flow metrics.
Annual Capital Reinvestment Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year Capital Reinvestment Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2024. See Hunan Dajiaweikang Pharmaceutical Indust (301126) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 7.78x | CN¥24.04 Million | CN¥187.14 Million | ▼ -6.8% |
| 2023 | 8.36x | CN¥27.13 Million | CN¥226.70 Million | ▲ +3394.0% |
| 2019 | 0.24x | CN¥135.91 Million | CN¥32.50 Million | — |